Crossmark

Colombian Association of Rheumatology. Consensus on recommendations to decrease and discontinue biological therapy in patients with rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis

Crossref DOI link: https://doi.org/10.1016/j.rcreue.2018.10.002

Published Print: 2019-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Jáuregui, Edwin

Bautista, Wilson

Beltrán, Adriana

Felipe, Oscar

Fernández, Andrés

Fernández, Daniel

Jaller, Juan José

Saldarriaga, Lina

Toro, Carlos
Funding

Funding for this research was provided by:

Colombian Association of Rheumatology
License Information

Text and Data Mining valid from 2019-01-01
More Information

This article is maintained by: Elsevier

Article Title: Colombian Association of Rheumatology. Consensus on recommendations to decrease and discontinue biological therapy in patients with rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis

Journal Title: Revista Colombiana de Reumatología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.rcreue.2018.10.002

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.rcreu.2018.10.011

Content Type: article

Copyright: © 2018 Asociación Colombiana de Reumatología. Published by Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below